How poor quality drugs are costing mothers their lives Impotent batches of life-saving oxytocin continue to fuel postpartum haemorrhage risks. Health 2 hours ago

Polycarp Oyoo, a senior programme officer at the International Centre for Reproductive Health Kenya, who is also a co-author in a study that flagged the quality of oxytocin, told the Nation that this is a major challenge, not just in Kenya, but in most low-resourced countries."Other than the cold chain issues, we also have issues around the quality of the active ingredients in oxytocin.

Michael Muthamia, senior regional project advisor and AMPLI-PPHI country programme manager at Jhpiego in Kenya, told the Nation that poor-quality oxytocin drugs are a "big problem.